Trexquant Investment LP

Position in MDXG — Mimedx Group, Inc.

CIK 1633445 STAMFORD, CT

Position in MDXG

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,004,233

+$218,260 QoQ

Shares Held

507,401

+92.3% QoQ

Ownership

0.341%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

10 quarters on record

Voting authority Sole 91.03687221743749.ToString("F0")% Shared 0.ToString("F0")% None 8.963127782562509.ToString("F0")%

Healthcare · as of Mar 31, 2026

Trexquant Investment LP holds $494,710,504 across 119 Biotechnology names. MDXG ranks #69 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	483,971	$24,585,726
2	ALNY	Alnylam Pharmaceuticals, Inc.	61,760	$20,434,531
3	ARWR	Arrowhead Pharmaceuticals, Inc.	277,114	$17,375,047
4	EXEL	Exelixis, Inc.	390,818	$16,762,184
5	HRMY	Harmony Biosciences Holdings, Inc.	594,850	$16,661,748
6	IONS	Ionis Pharmaceuticals Inc	213,645	$16,042,603
7	CNTA	Centessa Pharmaceuticals plc	390,951	$15,528,573
8	ASND	Ascendis Pharma A/S	65,517	$14,985,703

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,004,233	507,401	+92.3%	Shares	Sole	2026-05-15
2025-12-31	$1,785,973	263,807	+43.5%	Shares	Sole	2026-02-17
2025-06-30	$1,123,109	183,815	-55.7%	Shares	Sole	2025-08-12
2025-03-31	$3,153,103	414,882	+87.5%	Shares	Sole	2025-05-14
2024-12-31	$2,128,540	221,262	+29.7%	Shares	Sole	2025-02-12
2024-09-30	$1,008,405	170,627	+26.0%	Shares	Sole	2024-11-12
2024-06-30	$938,134	135,373	+88.7%	Shares	Sole	2024-08-13
2024-03-31	$552,428	71,744	+30.2%	Shares	Sole	2024-05-14
2023-06-30	$364,290	55,112	-30.2%	Shares	Sole	2023-08-11
2021-12-31	$477,238	79,013	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.